Czech Republic (CZ)

Exploring digital speech biomarkers of hypokinetic dysarthria in a multilingual cohort (2024) Kovac D, Mekyska J, Aharonson V, Harar P, Galaz Z, Rapcsak S, Orozco-Arroyave JR, et al. Journal article QKD Concepts and Considerations (2024) Naegele-Jackson S, Jacob Taquet E, Sanz A, Papastamatiou I, Rydlichowski P, Vojtech J, Andriantsarazo E, et al. Other publication type, Whitepaper Temperature-Dependent Twist of Double-Stranded RNA Probed by Magnetic Tweezer Experiments and Molecular Dynamics Simulations (2024) Dohnalová H, Seifert M, Matoušková E, Klein M, Stal Papini F, Lipfert J, Dulin D, Lankaš F Journal article Spliceosome malfunction causes neurodevelopmental disorders with overlapping features (2024) Li D, Wang Q, Bayat A, Battig MR, Zhou Y, Bosch DG, van Haaften G, et al. Journal article Logical states for fault-tolerant quantum computation with propagating light (2024) Konno S, Asavanant W, Hanamura F, Nagayoshi H, Fukui K, Sakaguchi A, Ide R, et al. Journal article The histone methyltransferase DOT1B is dispensable for stage differentiation and macrophage infection of Leishmania mexicana (2024) Eisenhuth N, Rauh ET, Mitnacht M, Debus A, Schleicher U, Butter F, Pruzinova K, et al. Journal article Unveiling the above-ground eukaryotic diversity supported by individual large old trees: the “Life on Trees” integrative protocol (2024) Leponce M, Basset Y, Aristizábal-Botero Á, Baïben N, Barbut J, Buyck B, Butterill P, et al. Journal article Corrigendum: An automatic measure for speech intelligibility in dysarthrias—validation across multiple languages and neurological disorders (Frontiers in Digital Health, (2024), 6, (1440986), 10.3389/fdgth.2024.1440986) (2024) Tröger J, Dörr F, Schwed L, Linz N, König A, Thies T, Barbe MT, et al. Journal article, Erratum Balancing Activity and Stability through Compositional Engineering of Ternary PtNi-Au Alloy ORR Catalysts (2024) Xie X, Briega-Martos V, Alemany P, Mohandas Sandhya AL, Skála T, Rodríguez MG, Nováková J, et al. Journal article Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party (2024) Duque-Afonso J, Finke J, Ngoya M, Galimard JE, Schetelig J, Eder M, Rösler W, et al. Journal article